Literature DB >> 9402264

Increased concentrations of renin, aldosterone and Ca125 in a case of spontaneous, recurrent, familial, severe ovarian hyperstimulation syndrome.

C Di Carlo1, P Bruno, D Cirillo, R Morgera, M Pellicano, C Nappi.   

Abstract

We report for the first time increased concentrations of aldosterone and renin in a case of spontaneous, recurrent, familial, severe ovarian hyperstimulation syndrome (OHSS). High concentrations of Ca125 were also found. Our patient was a 26 year old woman, gravida 2, para 1, affected by severe OHSS, who denied having ever consumed any ovulation drug. Both the patient and her only sister had suffered from a similar condition in their previous pregnancies. The patient was treated with i.v. fluid therapy. Paracentesis was performed on one occasion. The patient was dismissed after 25 days in good condition. Blood count and blood chemistry confirmed the severity of the clinical picture. We conclude that spontaneous OHSS, although very rare, may have been underestimated so far. It can be recurrent and may also be familial. The intra-ovarian prorenin-renin-angiotensin system may play a role in its aetiopathogenesis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9402264     DOI: 10.1093/humrep/12.10.2115

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  6 in total

Review 1.  Understanding ovarian hyperstimulation syndrome.

Authors:  Anne Delbaere; Guillaume Smits; Anne De Leener; Sabine Costagliola; Gilbert Vassart
Journal:  Endocrine       Date:  2005-04       Impact factor: 3.633

2.  Ovarian hyperstimulation syndrome after gonadotropin-releasing hormone agonist triggering and "freeze-all": in-depth analysis of genetic predisposition.

Authors:  Samuel Santos-Ribeiro; Nikolaos P Polyzos; Katrien Stouffs; Michel De Vos; Sara Seneca; Herman Tournaye; Christophe Blockeel
Journal:  J Assist Reprod Genet       Date:  2015-05-17       Impact factor: 3.412

Review 3.  New insights into the pathophysiology of ovarian hyperstimulation syndrome. What makes the difference between spontaneous and iatrogenic syndrome?

Authors:  A Delbaere; G Smits; O Olatunbosun; R Pierson; G Vassart; S Costagliola
Journal:  Hum Reprod       Date:  2004-01-29       Impact factor: 6.918

Review 4.  The molecular basis of impaired follicle-stimulating hormone action: evidence from human mutations and mouse models.

Authors:  Eric T Siegel; Hyung-Goo Kim; Hiromi Koso Nishimoto; Lawrence C Layman
Journal:  Reprod Sci       Date:  2012-11-26       Impact factor: 3.060

5.  Ovarian hyperstimulation syndrome in a spontaneous pregnancy: A potential for missed-diagnosis.

Authors:  James A Osaikhuwuomwan; Abieyuwa P Osemwenkha
Journal:  Niger Med J       Date:  2016 Jan-Feb

Review 6.  Spontaneous ovarian hyperstimulation syndrome in a nonpregnant female patient: a case report and literature review.

Authors:  Wei Chai; Hongyu He; Fei Li; Wenlei Zhang; Chao He
Journal:  J Int Med Res       Date:  2020-09       Impact factor: 1.671

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.